NIPSNAP3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.834040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.834800E-01
Normal-vs-Stage2
7.098100E-02
Normal-vs-Stage3
1.917880E-02
Normal-vs-Stage4
9.977000E-01
Stage1-vs-Stage2
5.845400E-01
Stage1-vs-Stage3
1.891190E-01
Stage1-vs-Stage4
5.151000E-01
Stage2-vs-Stage3
6.748300E-02
Stage2-vs-Stage4
3.738200E-02
Stage3-vs-Stage4
4.544500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.851820E-01
Normal-vs-AfricanAmerican
1.110590E-01
Normal-vs-Asian
4.064800E-01
Caucasian-vs-AfricanAmerican
7.324000E-01
Caucasian-vs-Asian
5.899800E-01
AfricanAmerican-vs-Asian
5.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.009440E-01
Normal-vs-Female
3.035600E-01
Male-vs-Female
2.843800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.286400E-02
Normal-vs-Age(41-60Yrs)
3.114000E-01
Normal-vs-Age(61-80Yrs)
1.570760E-01
Normal-vs-Age(81-100Yrs)
1.666150E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.661630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.650600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.848200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.227800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.613800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.009200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.806850E-01
Normal-vs-Daily Drinker
2.342600E-01
Normal-vs-Weekly Drinker
5.076100E-02
Normal-vs-Occasional Drinker
6.637000E-01
Normal-vs-Social Drinker
3.011200E-01
Non Drinker-vs-Daily Drinker
8.351000E-01
Non Drinker-vs-Weekly Drinker
5.606000E-01
Non Drinker-vs-Occasional Drinker
3.781400E-01
Non Drinker-vs-Social Drinker
4.849200E-01
Daily Drinker-vs-Weekly Drinker
4.623600E-01
Daily Drinker-vs-Occasional Drinker
4.711600E-01
Daily Drinker-vs-Social Drinker
6.356000E-01
Weekly Drinker-vs-Occasional Drinker
2.082600E-01
Weekly Drinker-vs-Social Drinker
2.142800E-01
Occasional Drinker-vs-Social Drinker
7.146000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.285600E-01
Normal-vs-Grade 2
3.078900E-03
Normal-vs-Grade 3
4.520500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.091400E-01
Grade 1-vs-Grade 3
6.983600E-01
Grade 1-vs-Grade 4
1.285600E-01
Grade 2-vs-Grade 3
5.457400E-01
Grade 2-vs-Grade 4
3.078900E-03
Grade 3-vs-Grade 4
4.520500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.460000E-02
Normal-vs-NonDiabetic
2.529600E-01
Diabetic-vs-NonDiabetic
1.421570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.697390E-01
Normal-vs-NoPancreatitis
2.057400E-01
Pancreatitis-vs-NoPancreatitis
9.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.277000E-01
Normal-vs-N1
8.087800E-02
N0-vs-N1
3.046200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.800810E-01
Normal-vs-TP53-NonMutant
3.198800E-01
TP53-Mutant-vs-TP53-NonMutant
9.915000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
